These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6014734)

  • 21. [Effect of olprinone hydrochloride on cerebral blood flow in patients after cardiac surgery].
    Goto K; Ito K; Takeshima N; Shingu C; Yoshitake S; Noguchi T
    Masui; 2000 Oct; 49(10):1088-91. PubMed ID: 11075555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent.
    Prichard BN; Owens CW; Graham BR
    J Hum Hypertens; 1997 Aug; 11 Suppl 1():S29-45. PubMed ID: 9321737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Studies on the pharmacokinetics and on the metabolism of 2(2,6-dichlorphenylamino)-2-imidazoline-hydrochloride (St 155)].
    Rehbinder D; Deckers W
    Arzneimittelforschung; 1969 Feb; 19(2):169-76. PubMed ID: 5818753
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of different classes of antihypertensive drugs on cerebral hemodynamics in elderly hypertensive patients.
    Fu CH; Yang CC; Kuo TB
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1621-5. PubMed ID: 16364836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of clofelin and apressin on blood circulation and metabolic indices of the brain].
    Sankina ZhV; Gaevyĭ MD
    Farmakol Toksikol; 1984; 47(5):32-6. PubMed ID: 6500032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Nilvadipine in the hypertensive elderly. Risk factor for cerebral insufficiency. Study report].
    Fortschr Med Monogr; 1993; 65():1-19. PubMed ID: 7728495
    [No Abstract]   [Full Text] [Related]  

  • 27. Influence of central inhibition of sympathetic nervous activity on myocardial metabolism in chronic heart failure: acute effects of the imidazoline I1-receptor agonist moxonidine.
    Mobini R; Fu M; Jansson PA; Bergh CH; Scharin Täng M; Waagstein F; Andersson B
    Clin Sci (Lond); 2006 Mar; 110(3):329-36. PubMed ID: 16209659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular effects of flutonidin after acute oral administration.
    Mazzola C; Guffanti E; Ferrario N
    Farmaco Prat; 1981 May; 36(5):262-70. PubMed ID: 7238849
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of enalapril on cerebral circulation and its autoregulation in hypertensive rats].
    Adzhienko LM; Asiedu DI
    Biull Eksp Biol Med; 1999 Jun; 127(6):642-4. PubMed ID: 10445129
    [No Abstract]   [Full Text] [Related]  

  • 30. [The acute effect of ST-155 hypotensive agent, on cardiac and renal hemodynamics].
    Vorburger C; Bütikofer E; Weiss S; Diacon C
    Helv Med Acta; 1967; 34(1):Suppl:133-4. PubMed ID: 5589186
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hypertension, antihypertensive therapy and cerebral circulation. A review].
    Strandgaard S
    Ugeskr Laeger; 1981 Jun; 143(23):1480-3. PubMed ID: 7281306
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of clofelin and apressin on the autoregulation of cerebral blood flow].
    Gaevyĭ MD; Sankina ZhV; Tkhak CK
    Farmakol Toksikol; 1983; 46(6):32-6. PubMed ID: 6653755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Characteristics of the action of gemiton, adelfan and dopegit on cerebral circulation in arterial hypertension].
    Eninia GI; Smeltere ES; Godlevska MA; Uzulinia IP
    Klin Med (Mosk); 1984 Mar; 62(3):100-3. PubMed ID: 6716915
    [No Abstract]   [Full Text] [Related]  

  • 34. [Circadian rhythms of hemodynamic load on the cardiovascular system in patients with essential hypertension: implication for drug therapy rationale].
    Komarov FI; Ol'binskaia LI; Khapaev VA
    Klin Med (Mosk); 2001; 79(3):52-5. PubMed ID: 11490420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of sulfocamphocaine on the systemic and cerebral hemodynamics of patients with chronic cerebral circulatory failure].
    Ishchenko MM; Shkrobot SI
    Vrach Delo; 1984 Jul; (7):68-70. PubMed ID: 6475025
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of pyrroxan and methylapogalanthamine on cerebral circulation and the brain's oxygen regime].
    Pogorelyĭ VE
    Farmakol Toksikol; 1981; 44(2):167-70. PubMed ID: 7274423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Indications for use of cardiac glycosides in complex treatment of hypertension].
    Erina EV; Beliaev SD
    Ter Arkh; 1980; 52(10):51-7. PubMed ID: 7444784
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of moxonidine monotherapy and in combination with melatonin on hemodynamic parameters in patients with arterial hypertension].
    Zaslavskaia RM; Komarov FI; Shakirova AN; Teĭblium MM; Akhmetov KZh
    Klin Med (Mosk); 2000; 78(4):41-4. PubMed ID: 10833890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of angiotensin II and antagonists of the renin-angiotensin system on the cerebral circulation].
    Adzhienko LM
    Eksp Klin Farmakol; 2000; 63(4):74-9. PubMed ID: 11022315
    [No Abstract]   [Full Text] [Related]  

  • 40. Central cardiovascular effects of flutonidine in adult fowls.
    Marmo E; Di Mezza F; Nistico G; Somma A; Ariello B; Imperatore A
    Agressologie; 1981; 22(6):269-72. PubMed ID: 7325301
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.